Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 6 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Opus Genetics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 50 | 49 | −1 |
| Shares | 3.71M | 3.37M | −338.7K (−9.1%) |
| Value | $11.2M | $6.78M | −$4.39M (−39.3%) |
New holders (8)
Institutions that held Opus Genetics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mackenzie Financial Corp | 40,814 | $82.0K | 0.00% |
| Empowered Funds, LLC | 36,605 | $73.6K | 0.00% |
| HRT Financial LP | 19,868 | $39.0K | 0.00% |
| Virtu Financial LLC | 17,752 | $36.0K | 0.00% |
| Summit Trail Advisors, LLC | 10,545 | $21.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 7,376 | $14.8K | 0.00% |
| Old Point Trust & Financial Services N A | 500 | $1.00K | 0.00% |
| Harbour Investments, Inc. | 40 | $80 | 0.00% |
Sold out (9)
Institutions that held Opus Genetics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Squarepoint Ops LLC | 61,152 | $184.1K |
| Anson Funds Management LP | 49,339 | $148.5K |
| Victory Capital Management Inc | 46,916 | $141.2K |
| Jane Street Group, LLC | 34,691 | $104.4K |
| LPL Financial LLC | 26,009 | $78.3K |
| United Bank | 11,800 | $35.5K |
| Group One Trading, L.P. | 708 | $2.13K |
| Bank of America Corp | 27 | $81 |
| GWM Advisors LLC | 19 | $57 |